Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise and Metformin in Colorectal and Breast Cancer Survivors
NCT01340300Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- May 2011
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in colorectal cancer (CRC), breast cancer, sponsored by Dana-Farber Cancer Institute. Started May 2011; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
colorectal cancer (CRC)breast cancer
Beyond the preview
Go deeper on NCT01340300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01340300.